Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma

Update your browser to view ScienceDirect.

Request details:

Request ID: 89983af6397615a4-SJC
IP: 101.37.83.79
UTC time: 2024-06-25T22:00:25+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4